Treatment of indolent lymphomas from watch and wait to high dose therapy

Author： Pangalis Gerassimos   Vassilakopoulos Theodoros   Kalpadakis Christina   Kyrtsonis Maria-Christina   Kokoris Styliani   Angelopoulou Maria   Panayiotidis Panayiotis  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.10, Iss.1, 2005-09, pp. : 6-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhanced efficacy of repeated anti-NCD8 monoclonal antibody therapy by high-dose cyclosporine treatment

By Allan J.S.   Slisz J.K.   Vesga L.   Arn J.S.   Yamada K.   Sachs D.H.   Madsen J.C.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4062-4063

Elsevier

Access to resources Recommend Favorite

Successful therapy with high-dose steroids and cyclosporine for the treatment of carmustine-mediated lung injury

By Zappasodi P.   Vitulo P.   Volpini E.   Castagnola C.   Nascimbene C.   Corso A.  

Annals of Hematology, Vol. 81, Iss. 6, 2002-06 ,pp. : 347-349

Springer Publishing Company

Access to resources Recommend Favorite

Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

By Tomizawa Daisuke   Tawa Akio   Watanabe Tomoyuki   Saito Akiko   Kudo Kazuko   Taga Takashi   Iwamoto Shotaro   Shimada Akira   Terui Kiminori   Moritake Hiroshi   Kinoshita Akitoshi   Takahashi Hiroyuki   Nakayama Hideki   Kiyokawa Nobutaka   Isoyama Keiichi   Mizutani Shuki   Hara Junichi   Horibe Keizo   Nakahata Tatsutoshi   Adachi Souichi  

International Journal of Hematology, Vol. 98, Iss. 5, 2013-11 ,pp. : 578-588

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders

By Cerny Jan   Trneny Marek   Slavickova Alena   Pytlik Robert   Salkova Jana   Valkova Veronika   Liu Qin   Houghton JeanMarie   Klener Pavel  

Hematology, Vol. 14, Iss. 4, 2009-08 ,pp. : 187-197

Maney Publishing

Access to resources Recommend Favorite

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study

By Uppenkamp M.   Engert A.   Diehl V.   Bunjes D.   Huhn D.   Brittinger G.  

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite